Sri Ram Exams logoSri Ram ExamsRead • Practice • Improve
Wednesday, 9 September 2026
September 9, 2026

UPSC Prelims 2025 GS Paper I Q48 — Monoclonal AntibodiesUPSC प्रीलिम्स 2025 GS पेपर I प्रश्न 48 — मोनोक्लोनल प्रतिरक्षी

About 2 min readPublished 9 September 2026
UPSC • Prelims • 2025 • Prelims GS Paper I Attempt the actual previous-year questions first. Official answer, analysis and elimination clue appear only after final submission.
Official Final Answer Key — Series A; 0 questions dropped; 100 questions scored 1 questions Official Question Paper ↗ Official Answer Key ↗
UPSC • Prelims • 2025 • Prelims GS Paper I
0 / 1
Question 48
UPSCScience & Technology2025Prelims GS Paper ISeries A

With reference to monoclonal antibodies, often mentioned in news, consider the following statements:

I. They are man-made proteins.

II. They stimulate immunological function due to their ability to bind to specific antigens.

III. They are used in treating viral infections like that of Nipah virus.

Which of the statements given above are correct?

समाचारों में अक्सर उल्लिखित मोनोक्लोनल प्रतिरक्षियों के संदर्भ में निम्नलिखित कथनों पर विचार कीजिए : I. ये मानव-निर्मित प्रोटीन हैं। II. विशिष्ट प्रतिजनों से बंधने की क्षमता के कारण ये प्रतिरक्षात्मक क्रिया को सक्रिय/प्रभावित करते हैं। III. निपाह विषाणु जैसे विषाणुजनित संक्रमणों के उपचार में इनका उपयोग किया जाता है। उपर्युक्त कथनों में से कौन-से सही हैं?

Official Final Answer Key — Series A; 0 questions dropped; 100 questions scored
Question 1 of 1
Useful? Share with other aspirants
Goldej Kumar
Author / EditorGoldej Kumar

Goldej Kumar is the Founder and Editor of Sri Ram Exams (Exam2.in), an independent educational platform for UPSC, State Public Service Commission, SSC and other competitive examinations. His editorial focus is on exam-relevant current affairs, source-based analysis, MCQ reasoning, previous-year-question patterns and clear bilingual learning for English- and Hindi-medium aspirants.